Month: September 2026

First patient marks Polyrizon’s transition into a clinical-stage company.

The U.S clinical study is designed to evaluate the efficacy, safety and tolerability of the NASARIX (PL-14) Allergy Blocker in patients with seasonal allergic rhinitis

Raanana, Israel, Sept. 22, 2026 (GLOBE NEWSWIRE) — Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a clinical- stage biotech company specializing in the development of innovative intranasal hydrogels, today announced the enrollment of the first patient in its U.S. clinical study to evaluate NASARIX (PL-14), the Company’s investigational Allergy Blocker, in patients with seasonal allergic rhinitis (SAR).

The enrollment of the first patient represents a significant milestone for Polyrizon and marks the Company’s transition into the clinical stage of development.

“This is a defining milestone for Polyrizon,” said Tomer Izraeli, Chief Executive Officer of Polyrizon. “The enrollment of the first patient in our U.S. study represents the culmination of extensive product development, preclinical evaluation, manufacturing and regulatory preparation, and moves NASARIX into clinical evaluation in patients for the first time. We believe this study represents an important step toward our goal of developing a differentiated, drug-free approach for people suffering from seasonal allergies.”

NASARIX is a non-pharmacological, drug-free, mucoadhesive hydrogel nasal spray designed to form a physical barrier within the nasal cavity. The barrier is intended to reduce contact between inhaled airborne allergens and the nasal mucosa, thereby helping alleviate symptoms associated with allergic rhinitis.

The prospective, multicenter, randomized, single-blind, two-arm study is expected to randomize 120 patients at 5 clinical sites in the United States. Participants will be randomized 1:1 to receive either NASARIX Allergy Blocker or a saline nasal spray comparator.

The study is designed to evaluate the efficacy, safety and tolerability of NASARIX in adults with seasonal allergic rhinitis. The primary efficacy endpoint will assess the difference in mean daily reflective Total Nasal Symptom Score (rTNSS) between PL-14 and the saline comparator over the first 14 treatment days. Safety assessments will include the frequency and severity of treatment-emergent adverse events as well as assessments of local and overall tolerability.

“Moving the NASARIX Allergy Blocker into a first-in-human clinical study is an important step in the development of our Capture and Contain™ technology from concept through product development and preclinical evaluation,” said Dr. Tidhar Turgeman, Chief Technology Officer of Polyrizon. “The study has been designed to generate data regarding efficacy and safety under real-world seasonal allergen exposure. We look forward to advancing enrollment across our U.S. clinical sites and evaluating NASARIX’s potential as a drug-free option for patients with seasonal allergic rhinitis.”

About NASARIX^TM

NASARIX^TM is Polyrizon’s proprietary nasal spray designed to create a protective barrier within the nasal cavity, helping to prevent contact between inhaled allergens and the nasal mucosa. The product is being developed as a non-drug approach for the management of seasonal allergic rhinitis.

About Polyrizon

Polyrizon is a clinical- stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Polyrizon’s proprietary Capture and Contain ^TM, or C&C, hydrogel technology, comprised of a mixture of naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a “biological mask” with a thin shield containment barrier in the nasal cavity. Polyrizon is further developing certain aspects of its C&C hydrogel technology, such as the bioadhesion and prolonged retention at the nasal deposition site for intranasal delivery of drugs. Polyrizon refers to its additional technology, which is in an earlier stage of pre-clinical development, that is focused on nasal delivery of active pharmaceutical ingredients, or APIs, as Trap and Target, or T&T. For more information, please visit https://polyrizon-biotech.com.

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses the expected conduct, timing and progress of the NASARIX (PL-14) clinical study, including patient enrollment, the anticipated number of patients and clinical sites, the study’s evaluation of efficacy, safety and tolerability, the generation of clinical data, and NASARIX’s potential as a drug-free option for patients with seasonal allergic rhinitis. Forward-looking statements are not historical facts, and are based upon management’s current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management’s expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company’s reports filed from time to time with the Securities and Exchange Commission (“SEC”), including, but not limited to, the risks detailed in the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2025 and subsequent filings with the SEC. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Polyrizon is not responsible for the contents of third-party websites.

Contacts:

Michal Efraty
Investor Relations
IR@polyrizon-biotech.com

Expands Access to Comprehensive Firefighter PPE Care with the Opening of its Colorado Facility

New Facility Provides Fire Departments with Cleaning, Inspection, Repair, Rental PPE, NFPA 1850 Training and Department Cleaning Equipment Under One Roof

HUNTSVILLE, Ala., Sept. 22, 2026 (GLOBE NEWSWIRE) — Lakeland Industries, Inc. (“Lakeland Fire + Safety” or “Lakeland”) (NASDAQ: LAKE) announced today the expansion of its network of independent service providers for comprehensive firefighter PPE care with the opening of its new Centennial, Colorado facility, Colorado PPE. Colorado PPE combines responsive department-focused service with the resources and capabilities of Lakeland Fire + Safety to deliver comprehensive PPE care, rental and training solutions.

Colorado PPE operates as an independent service provider, offering fire departments a more personal approach while bringing the resources and capabilities of a larger organization to the relationship. The facility represents a broader approach to firefighter PPE management—one that goes beyond compliance to focus on the people who rely on their gear every time they answer a call.

“We believe in maintaining a higher level of service for our fire departments,” said Mike Glaze, President of California PPE. “Our goal is to ensure our firefighters and departments are valued and their gear is in the best condition it can be in to protect them when it leaves our facility and enters their service.”

NFPA 1850, is the National Fire Protection Association standard that establishes requirements for the selection, care, maintenance, inspection, cleaning, repair, retirement, and management of protective ensembles and clothing used by firefighters and emergency responders. Under this standard, it establishes a minimum performance benchmark of removing 50% of heavy metals, polycyclic aromatic hydrocarbons (PAHs), and volatile organic compounds (VOCs) from contaminated PPE. Based on test results from UL, a third-party testing agency, our cleaning process achieved average cleaning efficiencies of 88% removal of VOCs and 89% removal of heavy metals—exceeding the minimum benchmark and raising the bar for PPE cleaning in the industry.

The new facility provides comprehensive PPE services designed to support firefighters throughout the lifecycle of their gear, including cleaning, inspection and repair. Rental PPE is also available to help departments maintain readiness when gear is temporarily out of service or when additional equipment is needed for training and other operational requirements. Colorado PPE will also provide NFPA 1850 training and station cleaning equipment such as extractors to help departments better understand and implement effective PPE care programs.

“Every department has different needs, different resources and different challenges. Our job is to understand those needs and help build a PPE care program that works for them,” said Misty Johnson, Operations Manager at Colorado PPE. “We clean, inspect and repair PPE with purpose—going beyond the minimum to help protect those who protect us because when it comes to protecting firefighters, meeting the minimum should be the starting point, not the finish line.”

Jim Jenkins, President and Chief Executive Officer of Lakeland, added, “Colorado PPE is committed to helping departments care for their gear with purpose and looks forward to serving the Colorado fire community. PPE care is ultimately about more than equipment, standards or processes. It is about the people wearing the gear. The firefighters who run toward emergencies trust their PPE to provide protection in some of the most demanding environments imaginable and Colorado PPE believes the care that gear receives should reflect the importance of that responsibility.”

About Lakeland Fire + Safety

Lakeland Fire + Safety manufactures and sells a comprehensive line of fire services and industrial protective clothing and accessories for the industrial and first responder markets. In addition, we provide decontamination, repair and rental services that complement our fire services portfolio. Our products are sold globally by our in-house sales teams, our customer service group, and authorized independent sales representatives to a strategic global network of selective fire and industrial distributors and wholesale partners. Our authorized distributors supply end users across various industries, including integrated oil, chemical/petrochemical, automobile, transportation, steel, glass, construction, smelting, cleanroom, janitorial, pharmaceutical, and high-tech electronics manufacturers, as well as scientific, medical laboratories, and the utilities industry. In addition, we supply federal, state and local governmental agencies and departments, including fire and law enforcement, airport crash rescue units, the Department of Defense, the Department of Homeland Security and the Centers for Disease Control. Internationally, we sell to a mix of end-users directly and to industrial distributors, depending on the particular country and market. In addition to the United States, sales are made into more than 50 foreign countries, the majority of which were into China, the European Economic Community (“EEC”), Canada, Chile, Argentina, Commonwealth of Independent States (“CIS”) Region, Colombia, Mexico, Ecuador, India, Uruguay, Middle East, Southeast Asia, Australia, Hong Kong and New Zealand.

For more information about Lakeland, please visit the Company’s website at www.lakeland.com.

About Colorado PPE

Located in Centennial, Colorado, Colorado PPE provides comprehensive PPE care and resources for fire departments, including cleaning, inspection, repair, rental PPE, NFPA 1850 training and equipment, and advanced decontamination solutions.

Colorado PPE combines the responsive, department-focused approach of an independent service provider with the resources, technical expertise and broader capabilities of Lakeland Fire + Safety. This combination allows Colorado PPE to deliver personal service at the local level while continuing to invest in technologies and capabilities designed to improve firefighter safety and PPE care. For more information visit https://coloradoppe.com/.

Colorado PPE
6675 S. Kenton St., Suite 113
Centennial, CO 80111

Hours: Monday–Friday, 8:00 a.m.-3:30 p.m. MT
Email: customerservice@coloradoppe.com

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995

This press release contains estimates, predictions, opinions, goals and other “forward-looking statements” as that phrase is defined in the Private Securities Litigation Reform Act of 1995. Such statements include, without limitation, references to the Company’s predictions or expectations of future business or financial performance as well as its goals and objectives for future operations, financial and business trends, business prospects, and management’s expectations for earnings, revenues, expenses, inventory levels, capital levels, liquidity levels, or other future financial or business performance, strategies or expectations, including without limitation our plans to deliver comprehensive care, rental and training solutions. All statements, other than statements of historical facts, which address Lakeland’s expectations of sources or uses for capital, or which express the Company’s expectation for the future with respect to financial performance or operating strategies, can be identified as forward-looking statements. Forward-looking statements involve risks, uncertainties and assumptions as described from time to time in press releases and Forms 8-K, registration statements, quarterly and annual reports and other reports and filings filed with the Securities and Exchange Commission or made by management. As a result, there can be no assurance that Lakeland’s future results will not be materially different from those described herein as “believed,” “projected,” “planned,” “intended,” “anticipated,” “can,” “estimated” or “expected,” or other words which reflect the current view of the Company with respect to future events. We caution readers that these forward-looking statements speak only as of the date hereof. The Company hereby expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in the Company’s expectations or any change in events, conditions or circumstances on which such statement is based, except as may be required by law.

Investor Relations
Chris Tyson
Executive Vice President
MZ Group – MZ North America
949-491-8235
LAKE@mzgroup.us 
www.mzgroup.us

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/1466df9b-0c9b-4b3c-a9ff-e4d7ba3b6eeb

https://www.globenewswire.com/NewsRoom/AttachmentNg/9ea55120-6143-4807-9908-cd5baf7bf773

https://www.globenewswire.com/NewsRoom/AttachmentNg/ae36e0fd-d833-4128-9654-cf7c4f179bac

https://www.globenewswire.com/NewsRoom/AttachmentNg/225c9d58-004e-40c7-b0fb-b9c41d3d91d6

https://www.globenewswire.com/NewsRoom/AttachmentNg/1eddf22f-adef-42a4-b74e-81a0a27d0cb3

https://www.globenewswire.com/NewsRoom/AttachmentNg/156dd466-2fdd-4937-b313-66a65fa7ec75

https://www.globenewswire.com/NewsRoom/AttachmentNg/913d3647-aadc-41cb-923b-ff7c5e36cb7a 

Approved Exploration Plan of Operations and 2026 Annual Operating Plan Clear the Way for Drilling; Company Targeting Up to 15,000 Feet of Additional Diamond Core Drilling This Season

BOISE, Idaho, Sept. 22, 2026 (GLOBE NEWSWIRE) — Idaho Copper Corporation (NYSE American: COPR) (“Idaho Copper” or the “Company”), a critical minerals developer advancing the flagship CuMo copper-molybdenum-silver project in Idaho, today announced that the U.S. Forest Service, Boise National Forest (“USFS”) sent a letter approving the Company’s Exploration Plan of Operations (“PoO”) and its 2026 annual operating plan for exploration at the CuMo project in Boise County, Idaho, clearing the way for drilling and roadbuilding and maintenance activities to commence.

On September 9, 2026, the USFS accepted the Company’s signed Forest Service Evaluation form and incorporated all required changes, modifications and mitigations into the approved PoO, and has accepted the Company’s reclamation surety bond. The letter further notes that the Company has provided documentation showing that all other permits necessary for the project are in place and in good standing. The USFS also approved the Company’s 2026 annual operating plan, which was reviewed and field verified by agency staff. The approved PoO is effective for six years from the first day of operations, inclusive of final reclamation.

The approval follows the Decision Notice and Finding of No Significant Impact issued by the USFS on March 14, 2025 under an Environmental Assessment, which completed the federal environmental review of the CuMo exploration plan. The September 9 letter satisfies the remaining administrative conditions to that decision and authorizes the Company to begin work.

Management Commentary

“Approval of our Exploration Plan of Operations and our 2026 annual operating plan is the culmination of a decade of work with the Forest Service, and it is the milestone that should turn CuMo from a concept into an active drill program,” said Andrew Brodkey, Chief Executive Officer of Idaho Copper. “We have an approved plan, an accepted reclamation bond, and the other permits this project requires. In a country where federal permitting is often the single largest obstacle impeding advancement of a critical minerals deposit, that is a meaningful achievement.”

“Our priority for the balance of this season is infill drilling that tightens confidence in the existing deposit, and we plan to carry that work into a substantially larger campaign in 2027 aimed at completing the drilling needed for a Prefeasibility Study. Every foot we drill from here will be directed at advancing CuMo toward a development decision, and at doing so under the environmental commitments we have made to the Forest Service and to the communities around this project,” concluded Brodkey.

About Idaho Copper Corporation

Idaho Copper Corporation (NYSE American: COPR) is a critical minerals developer focused on exploring and developing the CuMo copper-molybdenum-silver-tungsten-rhenium project located in Boise County, Idaho. The CuMo project is one of the largest undeveloped copper deposits in the U.S., which management believes is among the largest undeveloped primary molybdenum deposits in the world, which also contains significant amounts of silver, rhenium, and tungsten — all considered critical or of strategic importance. The project comprises approximately 2,640 acres and consists of 126 federal unpatented lode mining claims and 6 patented mining claims. To learn more, please visit www.idaho-copper.com.

Safe Harbor Statement

With the exception of historical information contained in this press release, content herein may contain “forward-looking statements” that are made pursuant to the Safe Harbor Provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identified by using words such as “anticipate,” “believe,” “plan,” “expect,” “intend,” “will,” and similar expressions, but these words are not the exclusive means of identifying forward-looking statements. Forward-looking statements in this release include statements regarding the Company’s 2026 and 2027 exploration and drilling programs, the expected footage, scope and timing thereof, and the planned Prefeasibility Study and the anticipated timing thereof. These statements are based on management’s current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made, including risks related to metal price volatility, mining and processing performance, drill rig and contractor availability, weather and the length of the permitted operating season, permitting, and the availability of financing for and development of the CuMo project. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements are discussed or identified in our filings with the Securities and Exchange Commission (the “SEC”), including the risk factors contained in our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and registration statements. In addition, this press release contains time-sensitive information that reflects management’s best analysis only as of the date of this press release. Idaho Copper does not undertake any obligation to publicly update or revise any forward-looking statements to reflect future events, information or circumstances that arise after the date of this release.

Investor Relations Contact:
Lucas A. Zimmerman
Managing Director
MZ Group – MZ North America
(262) 357-2918
COPR@mzgroup.us
www.mzgroup.us

Management to Participate in Gabelli Funds’ 4th Annual PFAS Symposium and Noble Capital Markets’ October 2026 Emerging Growth Virtual Equity Conference

CORSICANA, Texas, Sept. 22, 2026 (GLOBE NEWSWIRE) — Birchtech Corp. (NYSE American: BCHT) (TSX: BCHT) (“Birchtech” or the “Company”), a leader in specialty activated carbon technologies for sustainable air and water treatment, today announced that management will participate in two upcoming investor conferences: Gabelli Funds’ 4th Annual PFAS Symposium and Noble Capital Markets’ October 2026 Emerging Growth Virtual Equity Conference.

Richard MacPherson, President and CEO of Birchtech, is scheduled to deliver a corporate presentation at each event and will host one-on-one meetings with institutional investors at the Noble Capital Markets conference, as follows:

Gabelli Funds’ 4th Annual PFAS Symposium
Conference Date: September 24, 2026
Location: Convene, 530 Fifth Avenue, New York, NY
Format: Presentation Only
Presentation Time: 2:30 PM Eastern Time
Webcast: https://gabelli.com/event/4th-annual-pfas-symposium/

Noble Capital Markets’ October 2026 Emerging Growth Virtual Equity Conference
Conference Dates: October 1-2, 2026
Location: Virtual
Format: Presentation & 1×1 Meetings
Presentation Date: October 2, 2026
Presentation Time: 1:00 PM Eastern Time
Webcast: https://channelchek.cc/3TmsB7g

A live audio webcast and archive of each presentation will be available using the webcast links above. Registration is mandatory for conference participation. For more information or to schedule a meeting with management, please contact MZ Group at BCHT@mzgroup.us.

About Birchtech Corp.

Birchtech Corp. (NYSE American: BCHT) (TSX: BCHT) is a leader in specialty activated carbon technologies delivering innovative solutions for air and water purification to support a cleaner, more sustainable future. The Company provides patented SEA^® sorbent technologies for mercury emissions capture for the coal-fired utility sector and SEA disruptive water purification technologies with a specialization on removing contaminants, including ‘forever chemicals’ such as PFAS, from potable water and industrial wastewater. Backed by a strong intellectual property portfolio and a team of activated carbon experts, Birchtech provides cleaner air to North American communities and is applying this expertise to a novel approach in water purification. To learn more, please visit www.birchtech.com.

Safe Harbor Statement

With the exception of historical information contained in this press release, content herein may contain “forward-looking statements” that are made pursuant to the Safe Harbor Provisions of the U.S. Private Securities Litigation Reform Act of 1995 or forward-looking information under applicable Canadian securities laws (collectively, “forward-looking statements”). Forward-looking statements are generally identified by using words such as “anticipate,” “believe,” “plan,” “expect,” “intend,” “will,” and similar expressions, but these words are not the exclusive means of identifying forward-looking statements. Forward-looking statements in this release include statements relating to expected developments and growth in Birchtech’s business, as well as anticipated investor engagements and the Company’s participation in investor conferences. These statements are based on management’s current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. In addition, this release contains time-sensitive information that reflects management’s best analysis only as of the date of this release. Birchtech does not undertake any obligation to publicly update or revise any forward-looking statements to reflect future events, information or circumstances that arise after the date of this release. Further information concerning issues that could materially affect financial performance or other forward-looking statements contained in this release can be found in Birchtech’s periodic filings with the Securities and Exchange Commission or Canadian securities regulators.

Investor Relations Contact:
Lucas A. Zimmerman
Managing Director
MZ Group – MZ North America
(949) 259-4987
BCHT@mzgroup.us
www.mzgroup.us

This article has been disseminated on behalf of MAX Power Mining Corp. and may include a paid advertisement.

Disclosure: This does not represent material news, partnerships or investment advice.

NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) — via AINewsWire — MAX Power Mining Corp. (OTC: MAXXF) (CSE: MAXX) today announces its placement in an editorial published by AINewsWire (AINW), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.

To view the full publication, “What If the Next Generation of AI Data Centers Goes to the Energy Source?”, please visit: https://ibn.fm/awVTg

Artificial intelligence may be transforming what computers can do, but the next phase of that revolution increasingly depends on something far more fundamental: electricity. As AI data centers grow larger and more power intensive, governments and technology companies are confronting a question that could reshape both the energy and digital-infrastructure industries: What if, instead of continually moving energy to data centers, the next generation of data centers is built where abundant primary energy already exists?

That possibility is particularly relevant to MAX Power Mining Corp., a leading North American public company focused on the emerging natural hydrogen sector. MAX Power is advancing Canada’s first confirmed subsurface natural hydrogen system at the Lawson Discovery in south-central Saskatchewan, where the company is moving rapidly through a multi-well commercial validation program.

About MAX Power Mining Corp.

MAX Power is an innovative mineral and energy exploration company focused on the shift to decarbonization. The company’s Lawson Discovery near Central Butte, Saskatchewan, represents Canada’s first-ever subsurface natural hydrogen system confirmed through deep drilling with data validated by three independent labs. MAX Power has built dominant district-scale land positions across Saskatchewan with approximately 1.3 million acres (521,000 hectares) of permits covering prime exploration ground prospective for large-volume accumulations of natural hydrogen. MAX Power also holds a portfolio of properties in the United States and Canada focused on critical minerals. These properties are highlighted by a 2024 diamond drilling discovery at the Willcox Playa Lithium Project in southeast Arizona, 100%-owned by MAX Power’s U.S. subsidiary. MAX Power is committed to responsible exploration and development practices that prioritize environmental stewardship, meaningful community engagement and strong corporate governance.

For further information, please visit the company’s website at www.MAXPowerMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MAXXF are available in the company’s newsroom at https://ibn.fm/MAXXF

About AINewsWire

AINewsWire (“AINW”) is a specialized communications platform with a focus on the latest advancements in artificial intelligence (“AI”), including the technologies, trends and trailblazers driving innovation forward. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, AINW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, AINW brings its clients unparalleled recognition and brand awareness.

AINW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from AINewsWire, text “AI” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit www.AINewsWire.com

Please see full terms of use and disclaimers on the AINewsWire website applicable to all content provided by AINW, wherever published or republished: https://www.AINewsWire.com/Disclaimer

AINewsWire
Austin, Texas
www.AINewsWire.com
512.354.7000 Office
Editor@AINewsWire.com

AINewsWire is powered by IBN

NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) — via AINewsWire — Nightfood Holdings Inc. (OTCQB: NGTF) today announces its placement in an editorial published by AINewsWire (“AINW”), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.

To view the full publication, “Wafer Inspection Market Set to Approach $10 Billion by 2030,” please visit: https://ibn.fm/FpZPM

The artificial intelligence boom has moved its toughest bottleneck. It is no longer just about who can etch the smallest transistor. Increasingly, it is about who can package finished chips fast enough, cleanly enough and in high enough volume to keep AI data centers supplied. NVIDIA CEO Jensen Huang has said publicly that the company is expanding capacity for CoWoS-L, the advanced packaging process behind its newest chips, while continuing to push suppliers on yield and production speed.

That same pressure is now rippling through the automation and inspection layer that supports packaging lines, an area where Nightfood Holdings Inc. (OTCQB: NGTF), doing business as TechForce Robotics, intends to compete. Last week, the company announced the formation of TechForce Advanced Manufacturing Inc., a majority-owned subsidiary built with a Taiwan-based manufacturing partner to expand production of automated Wafer Sorter and AOI systems for 8-inch and 12-inch wafers, with initial production and revenue targeted for the fourth quarter of 2026. 

About Nightfood Holdings Inc. (dba TechForce Robotics)

Nightfood Holdings Inc., doing business as TechForce Robotics, is an advanced robotics and automation company focused on delivering intelligent, scalable solutions for industrial and commercial applications. The company integrates robotics, artificial intelligence and software-driven systems to optimize operations, improve efficiency and enable next-generation automation. TechForce Robotics partners with organizations to design and deploy customized robotic solutions that address evolving operational requirements.

About TechForce Advanced Manufacturing
TechForce Advanced Manufacturing Inc. is a Nevada corporation formed to develop, manufacture, commercialize, install and support semiconductor automation and inspection systems. Its initial focus is expanding Wafer Sorter and AOI production for wafer-based semiconductor and CoWoS-related advanced-packaging applications, while pursuing future applications supporting emerging Chip-on-Panel-on-Substrate (“CoPoS”) manufacturing process.

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at http://ibn.fm/NGTF

For more information, visit Nightfood Holdings.

About AINewsWire

AINewsWire (AINW) is a specialized communications platform with a focus on the latest advancements in artificial intelligence (“AI”), including the technologies, trends and trailblazers driving innovation forward. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, AINW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, AINW brings its clients unparalleled recognition and brand awareness.

AINW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from AINewsWire, text “AI” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit www.AINewsWire.com

DISCLAIMER: AINewsWire (AINW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by AINW are solely those of AINW. Readers of this Article and content agree that they cannot and will not seek to hold liable AINW for any investment decisions by their readers or subscribers. AINW is a news dissemination and financial marketing solutions provider and NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, AINW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

AINW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may,”, “future,” “plan” or “planned,” “will” or “should,” “expected,” “anticipates,” “draft,” “eventually,” or “projected.” You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and AINW undertakes no obligation to update such statements.

Please see full terms of use and disclaimers on the AINewsWire website applicable to all content provided by AINW, wherever published or re-published: 
https://www.AINewsWire.com/Disclaimer

AINewsWire
Austin, Texas
www.AINewsWire.com
512.354.7000 Office
Editor@AINewsWire.com

AINewsWire is powered by IBN

Not for distribution to U.S. newswire services or for dissemination in the United States.

TORONTO, Sept. 22, 2026 (GLOBE NEWSWIRE) — (TSX: PGIC; PGIC.PR.A) – Premium Global Income Split Fund (the “Fund”) is pleased to announce it has established an at-the-market equity program (“ATM Program”) that allows the Fund to issue preferred shares and class A shares to the public from time to time, at the Fund’s discretion. The program replaces the prior program that was established in December 2024 that has terminated. Any preferred shares or class A shares sold under the ATM Program will be sold through the Toronto Stock Exchange (the “TSX”) or any other marketplace in Canada on which the class A shares and preferred shares are listed, quoted or otherwise traded at the prevailing market price at the time of sale. Sales of class A shares and preferred shares through the ATM Program will be made pursuant to the terms of an equity distribution agreement dated September 21, 2026 (the “Equity Distribution Agreement”) with National Bank Financial Inc. (the “Lead Agent”) and CIBC World Markets Inc. (together with the Lead Agent, the “Agents”).

Sales of class A shares and preferred shares will be made by way of “at-the-market distributions” as defined in National Instrument 44-102 Shelf Distributions on the TSX or on any marketplace for the class A shares and preferred shares in Canada. Since the class A shares and preferred shares will be distributed at the prevailing market prices at the time of the sale, prices may vary among purchasers during the period of distribution. The ATM Program is being offered pursuant to a prospectus supplement dated September 21, 2026, to the Fund’s short form base shelf prospectus dated August 21, 2026. The maximum gross proceeds from the issuance of the shares will be $70,000,000. Copies of the prospectus supplement and the short form base shelf prospectus may be obtained from your registered financial advisor using the contact information for such advisor, or from representatives of the Agents and are available on SEDAR+ at www.sedarplus.com.

The volume and timing of distributions under the ATM Program, if any, will be determined at the Fund’s sole discretion. The new program will be effective until September 20, 2028, unless terminated prior to such date in accordance with the terms of the Equity Distribution Agreement. The Fund intends to use the proceeds from the ATM Program in accordance with the investment objectives and investment strategies of the Fund, subject to the investment restrictions of the Fund.

The Fund invests in a diversified portfolio of primarily large capitalization global equity securities actively selected by its manager and investment manager, Mulvihill Capital Management Inc. (“Mulvihill”). To enhance the income generated by the Fund’s portfolio and to reduce volatility, the Fund employs an active covered call writing strategy and may write cash covered put options in respect of securities in which it is permitted to invest. The Fund may also invest up to 100% of its net assets in other public investment funds (including investment funds managed by Mulvihill). In addition, the Fund is exposed to securities traded in foreign currencies and may, at Mulvihill’s discretion, enter into currency hedging transactions to reduce the effects of changes in the value of foreign currencies relative to the value of the Canadian dollar.

For further information, please contact Investor Relations at 416.681.3966, toll free at 1.800.725.7172, email at info@mulvihill.com or visit www.mulvihill.com

John Germain, Senior Vice-President & CFO	Mulvihill Capital Management Inc. 25 King Street West Suite 2110 Toronto, Ontario, M5L 1A1

A short form base shelf prospectus and prospectus supplement containing important detailed information about the securities being offered has been filed with securities commissions or similar authorities in each of the provinces of Canada. Copies of the short form base shelf prospectus may be obtained from the Agents. Investors should read the short form base shelf prospectus and the prospectus supplement before making an investment decision.

You will usually pay brokerage fees to your dealer if you purchase or sell shares of the investment fund on the TSX. If shares of the Fund are purchased or sold on the TSX, investors may pay more than the current net asset value when buying shares of the investment fund and may receive less than the current net asset value when selling them.

There are ongoing fees and expenses associated with owning shares of an investment fund. An investment fund must prepare disclosure documents that contain key information about the fund. You can find more detailed information about the investment fund in these documents. Investment funds are not guaranteed, their values change frequently and past performance may not be repeated.

The securities offered have not been registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or any applicable exemption from the registration requirements. This news release does not constitute an offer to sell or the solicitation of an offer to buy securities nor will there be any sale of such securities in any state in which such offer, solicitation or sale would be unlawful.

Winnipeg Blue Bombers Select Clover to Support Game-Day Commerce

MILWAUKEE, Sept. 22, 2026 (GLOBE NEWSWIRE) — Fiserv, Inc. (NASDAQ: FISV), a leading global provider of payments and financial services technology, today announced that the Winnipeg Blue Bombers of the Canadian Football League (CFL) have selected Clover to power commerce operations across its venue. This partnership represents an important milestone in Fiserv’s growth across Canada, expanding its presence within the country’s sports, entertainment, and hospitality ecosystems.

“Today, Clover supports six of the nine CFL venues, helping organizations deliver fast, reliable, and seamless commerce experiences for fans through integrated payment acceptance and venue operations tools,” said Brian Green, General Manager of Clover Canada at Fiserv. “The Winnipeg Blue Bombers partnership is the most recent example of Clover’s growth across Canada, reinforcing our position as a leading commerce platform used in venues across the region. We’re excited to support the Blue Bombers and help sports and entertainment organizations modernize operations, enhance fan experiences, and drive growth.”

Designed for high-volume, peak-event environments, Clover delivers a solution that combines payment processing, point-of-sale technology, and venue management capabilities within a single platform. In addition to providing an enhanced fan experience, Clover is designed to support the reliability requirements of high-volume venues to help ensure business continuity during events, including LTE connectivity, Wi-FI flexibility and offline transaction capabilities.

“Clover empowers our staff at Princess Auto Stadium to provide a top quality experience to our fans,” said Blue Bombers President & CEO Wade Miller. “It has a strong reputation across other CFL stadiums, and as a valued partner, we’re excited that we can now work together to enhance our stadium operations based on the Clover team’s expertise and the power of Fiserv technology.”

Beyond speed and reliability, venue operators gain access to centralized operational reporting and actionable business insights to streamline back-of-house operations. This newest customer addition to the Clover portfolio further positions Fiserv for continued expansion across arenas, concert halls, and entertainment destinations seeking end-to-end commerce solutions.

For more information about Clover, visit https://www.clover.com/ca.

About Fiserv
Fiserv, Inc. (NASDAQ: FISV), a Fortune 500 company, is a global leader uniting commerce and finance. The company powers sustained growth and innovation at scale for financial institutions and businesses worldwide across payments, account processing, digital banking, merchant acquiring, network services, e-commerce, and Clover^®, the all-in-one business management platform. Fiserv is a member of the S&P 500^® Index and one of FORTUNE^® America’s Most Innovative Companies. Visit fiserv.com and follow on social media for more information and the latest company news.

Media Relations:

Fiserv, Inc.
Melissa Moritz
Vice President, External Communications
melissa.moritz@fiserv.com   

Winnipeg Blue Bombers
Darren Cameron
Senior Vice President, Team Strategy & Public Relations
Winnipeg Blue Bombers
P: (204) 784-7422 | C: (204) 292-9587
dcameron@bluebombers.com | www.bluebombers.com

MIAMI, Sept. 22, 2026 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced presentations at the upcoming 62^nd Annual Meeting of the European Association for the Study of Diabetes (EASD) being held September 28 – October 2, 2026 in Milan, Italy. Presented data will highlight SAB BIO’s lead program, SAB-142, a potentially disease-modifying, redosable immunotherapy in clinical development for the treatment of Stage 3 T1D.

“We are honored to present and participate at the EASD Annual Meeting, which provides an important opportunity to engage with the global diabetes community as type 1 diabetes research increasingly focuses on preserving endogenous insulin production and modifying the course of disease,” said Alexandra Kropotova, M.D., MBA, Chief Medical Officer, SAB BIO. “Our presentations highlight SAB-142 Phase 1 data, including its mechanism of action, potential for safe redosing, and early evidence of C-peptide preservation. We look forward to engaging with the scientific community as SAB-142 continues to advance through the registrational SAFEGUARD study.”

Oral Presentations at EASD Annual Meeting 2026:

Title: SAB-142: ​Setting a New ​Standard for Beta-Cell Preservation​
Session: INNODIA Symposium on Type 1 Diabetes Therapies
Presenter: Alexandra Kropotova, M.D., MBA, Chief Medical Officer, SAB BIO
Presentation Date and Time: Monday, September 28, 2026, 3:00 – 5:25 PM CEST
Location: Berlin Hall, Milan Convention Centre, Piazzale Carlo Magno 1, Milan, Italy

Title: Mechanism of action of SAB-142 and responsive C-peptide signal in adult patients with type 1 diabetes > 100 days post diagnosis*
Session: Can we stop type 1 diabetes?
Presenter: Christoph Bausch, PhD, MBA, Chief Operating Officer, SAB BIO
Presentation Date and Time: Wednesday, September 30, 2026, 1:00 – 2:00 PM CEST
Location: Station 03, Milan Convention Centre, Piazzale Carlo Magno 1, Milan, Italy

Title: SAB-142, a fully human anti-thymocyte globulin, can be safely readministered, is not immunogenic, and has predictable PK/PD profiles in healthy volunteers*
Session: Can we stop type 1 diabetes?
Presenter: William Quinn, PhD, Executive Director, Immunology, SAB BIO
Presentation Date and Time: Wednesday, September 30, 2026, 1:00 – 2:00 PM CEST
Location: Station 03, Milan Convention Centre, Piazzale Carlo Magno 1, Milan, Italy

Title: SAB-142, a fully human anti-thymocyte globulin, demonstrated anticipated PD profiles and early efficacy signals in T1D patients with residual C-peptide* 
Session: Can we stop type 1 diabetes?
Presenter: William Quinn, PhD, Executive Director, Immunology, SAB BIO
Presentation Date and Time: Wednesday, September 30, 2026, 1:00 – 2:00 PM CEST
Location: Station 03, Milan Convention Centre, Piazzale Carlo Magno 1, Milan, Italy

*Each of these sessions will also be available as poster presentations (ePID2235, ePID2238, ePID2240) in the ePoster Area – North Wing, Central Building – in the Milan Convention Centre, Piazzale Carlo Magno 1, Milan, Italy.

The presentations will be made available in the Presentations section of the Company’s website afterwards and will remain accessible following the conference.

About SAB-142
SAB-142 is a potentially disease-modifying, redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes (T1D). SAB-142 is a multi-specific, fully human anti-thymocyte globulin (hATG) with a mechanism of action analogous to that of rabbit ATG (rATG). rATG has demonstrated in multiple clinical trials the ability to slow disease progression in patients with new- or recent-onset of Stage 3 T1D. SAB-142, like rATG, directly targets multiple immune cells involved in destroying pancreatic beta cells, including modulation of “bad acting” T-lymphocytes. By stopping immune cells from attacking beta cells, this treatment has the potential to preserve insulin-producing beta cells.

About SAB BIO
SAB BIO is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. Using advanced genetic engineering and antibody science, SAB BIO developed a proprietary technology which holds the potential to generate additional novel therapeutic candidates utilizing the human immune response, without the need for human donors or convalescent plasma. SAB BIO has optimized genetic engineering in the development of transchromosomic cattle, or Tc-Bovine, to produce hIgG. SAB BIO’s drug development production system is able to generate a diverse repertoire of specifically targeted, high-potency, hIgGs that can address a wide range of serious unmet needs in human diseases. The Company’s lead candidate, SAB-142, targets autoimmune T1D with a disease-modifying therapeutic approach that aims to change the T1D treatment paradigm by delaying onset and potentially preventing disease progression of Stage 3 T1D patients. SAB-142 is currently being evaluated in newly diagnosed Stage 3 autoimmune T1D patients in a registrational Phase 2b clinical trial called SAFEGUARD. For more information, visit www.sab.bio.

Forward-Looking Statements
Certain statements made in this press release that are not historical facts are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “to be,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding future events, including statements about the development and clinical trial results of the Company’s T1D program and other discovery programs.

These statements are based on the current expectations of SAB BIO and are not predictions of actual performance, and are not intended to serve as, and must not be relied on, by any investor as a guarantee, prediction, definitive statement, or an assurance, of fact or probability. These statements are only current predictions or expectations, and are subject to known and unknown risks, uncertainties and other factors which may be beyond our control. Actual events and circumstances are difficult or impossible to predict, and these risks and uncertainties may cause our or our industry’s results, performance, or achievements to be materially different from those anticipated by these forward-looking statements. A further description of risks and uncertainties can be found in the sections captioned “Risk Factors” in our most recent annual report on Form 10-K, subsequent quarterly reports on Form 10-Q, as may be amended or supplemented from time to time, and other filings with or submissions to, the U.S. Securities and Exchange Commission, which are available at https://www.sec.gov/. Except as otherwise required by law, SAB BIO disclaims any intention or obligation to update or revise any forward-looking statements, which speak only as of the date they were made, whether as a result of new information, future events, or circumstances or otherwise.

CONTACTS

Investor Relations:
Christine Ryan
ir@sab.bio

Media:
Sheila Carlson
media@sab.bio